NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 34 filers reported holding NUVECTIS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 116,380 | $1,500,138 | 0.13% |
| FORBES J M & CO LLP | 34,000 | $438,260 | 0.06% |
| Moran Wealth Management, LLC | 16,697 | $215,224 | 0.01% |
| Dorsey Wright & Associates | 1,396 | $17,994 | 0.01% |
| Tower Research Capital LLC (TRC) | 7,282 | $93,865 | 0.00% |
| MARSHALL WACE, LLP | 36,085 | $465,136 | 0.00% |
| Renaissance Technologies | 25,400 | $327 | 0.00% |
| UBS Group AG | 3,776 | $48,672 | 0.00% |
| RHUMBLINE ADVISERS | 7,273 | $93,742 | 0.00% |
| HOLLENCREST CAPITAL MANAGEMENT | 280 | $3,609 | 0.00% |